Recruiting
Phase 2
Phase 3

Impact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington Disease

Sponsor:

Vanderbilt University Medical Center

Code:

NCT04713982

Conditions

Huntington Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Deutetrabenazine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information